Court Issues Notice To Serum Institute Of India On Suit Against Use Of Name 'COVISHIELD' For Proposed Vaccine
Share This -
x
A civil court in Maharashtra has issued notice to the Serum Institute of India(SII) in a passing off suit seeking to restrain the pharmaceutical company from using the trademark "COVISHIELD" or "COVID-SHIELD" or any other identical or similar name for its proposed vaccine for the Coronavirus induced pandemic.The civil suit was filed by a Nanded-based pharmaceutical company "Cutis Biotech"...
Your free access to Live Law has expired
To read the article, get a premium account.
Your Subscription Supports Independent JournalismSubscription starts from